Voigtmann Inc

Healthcare IT - Mass Screening Platform for Autonomous & Automated Diagnosis of Diabetic Retinopathy and other Retina related problems plus TeleHealth App for care coordination. - Fundraising mode activated - let’s talk ! The American startup Voigtmann Inc is a spin-out of Voigtmann GmbH, an German IT company. We are on a mission to prevent avoidable BLINDNESS in Diabetics with ITOS, our mass screening platform to early predict Diabetic Retinopathy and other retina related problems. Our autonomous and automated system works without medical staff, does neither need eye drops nor internet and is therefore also prone to reach people in remotest rural areas – all with a comparably tiny carbon footprint. Our system is EU and Mexican regulated and early in the market. We renew healthcare with our novel approach to convenient, precise and affordable eye screenings so no one has to go blind. Our additional TeleHealth App can cut cure pathways short. We follow UN Sustainable Development Goals (SDGs): #3 (Good HEALTH), #9 (Industry, INNOVATION and INFRASTRUCTURE), #8 (Decent WORK and Economic Growth), #12 ( Affordable Energy, Responsible CONSUMPTION and PRODUCTION), and #4(inclusive, quality EDUCATION)